Toward Personalized Medicine: Using Cardiomyocytes Differentiated From Urine-Derived Pluripotent Stem Cells to Recapitulate Electrophysiological Characteristics of Type 2 Long QT Syndrome

Journal of the American Heart Association
Mariam JouniNathalie Gaborit

Abstract

Human genetically inherited cardiac diseases have been studied mainly in heterologous systems or animal models, independent of patients' genetic backgrounds. Because sources of human cardiomyocytes (CMs) are extremely limited, the use of urine samples to generate induced pluripotent stem cell-derived CMs would be a noninvasive method to identify cardiac dysfunctions that lead to pathologies within patients' specific genetic backgrounds. The objective was to validate the use of CMs differentiated from urine-derived human induced pluripotent stem (UhiPS) cells as a new cellular model for studying patients' specific arrhythmia mechanisms. Cells obtained from urine samples of a patient with long QT syndrome who harbored the HERG A561P gene mutation and his asymptomatic noncarrier mother were reprogrammed using the episomal-based method. UhiPS cells were then differentiated into CMs using the matrix sandwich method.UhiPS-CMs showed proper expression of atrial and ventricular myofilament proteins and ion channels. They were electrically functional, with nodal-, atrial- and ventricular-like action potentials recorded using high-throughput optical and patch-clamp techniques. Comparison of HERG expression from the patient's UhiPS-CMs to...Continue Reading

References

Jul 29, 2004·Molecular Pharmacology·Chloé BellocqIsabelle Baró
Feb 17, 2006·European Journal of Pharmacology·Clemens Möller, Rainer Netzer
Nov 22, 2007·Science·Junying YuJames A Thomson
Dec 7, 2007·Nature Biotechnology·Masato NakagawaShinya Yamanaka
Jan 23, 2009·Annals of Medicine·Annukka MarjamaaKimmo Kontula
Feb 14, 2009·Circulation Research·Jianhua ZhangTimothy J Kamp
Dec 10, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Karim Si-TayebStephen A Duncan
Jan 18, 2011·Nature·Ilanit ItzhakiLior Gepstein
Mar 11, 2011·PloS One·Junying YuYong Jiang
Jul 6, 2011·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Keisuke Okita, Shinya Yamanaka
Aug 7, 2012·Cell Transplantation·Ana SepacJohn W Lough
Oct 23, 2012·Analytical Biochemistry·Anne GürtlerAnton Posch
Nov 10, 2012·Nature Protocols·Ting ZhouMiguel A Esteban
Jan 2, 2013·The Journal of General Physiology·Cecile TerrenoireRobert S Kass
Jan 3, 2013·The Journal of Clinical Investigation·Silvia G PrioriGianluigi Condorelli
Jun 15, 2013·Stem Cells International·Martin MüllerJörg Homann
Sep 24, 2013·Trends in Cardiovascular Medicine·Fabian ZanellaFarah Sheikh
Nov 26, 2013·The American Journal of Pathology·Sabine Gerbal-ChaloinKarim Si-Tayeb
Feb 7, 2014·The EMBO Journal·Haruhisa InoueShinya Yamanaka

❮ Previous
Next ❯

Citations

Dec 19, 2017·Stem Cells International·Xiaoli JiJunmei Zhou
Sep 9, 2017·Disease Models & Mechanisms·Karina O BrandãoRichard P Davis
Jun 7, 2018·Circulation. Genomic and Precision Medicine·Kiran MusunuruUNKNOWN American Heart Association Council on Functional Genomics and Translational Biology; Council on Cardiovascular Disease in th
Jan 27, 2019·Expert Opinion on Biological Therapy·Wenbin LiangDarryl R Davis
Feb 28, 2019·The Journal of Biological Chemistry·Olfat A MalakGildas Loussouarn
May 11, 2019·Journal of Clinical Medicine·Maria Sofia Falzarano, Alessandra Ferlini
Mar 25, 2016·Nature Reviews. Cardiology·Ian Y ChenJoseph C Wu
Nov 15, 2019·Cell Transplantation·Aline Yen Ling Wang, Charles Yuen Yung Loh
May 23, 2019·Arrhythmia & Electrophysiology Review·Luca SalaPeter J Schwartz
Feb 22, 2017·Current Cardiology Reports·Alexander GoedelAlessandra Moretti
Jan 11, 2020·Frontiers in Molecular Neuroscience·Mitsuto SatoYoshitsugu Aoki
May 8, 2020·Cardiology Research and Practice·Ping HuangPing Zhu
May 21, 2020·Frontiers in Pharmacology·Kathryn R BrewerCharles R Sanders
Nov 4, 2016·Physiological Reviews·M S BohnenR S Kass
Oct 2, 2020·International Journal of Molecular Sciences·Stephan De WaardMichel De Waard
Oct 10, 2020·The Biochemical Journal·Stephan De WaardMichel Ronjat
Sep 9, 2020·Cardiovascular Research·Zeina R Al SayedNathalie Gaborit
Nov 13, 2020·World Journal of Stem Cells·Perrine BurdeyronClara Steichen
Dec 17, 2020·Journal of Cardiovascular Pharmacology·Michelangelo PaciJussi T Koivumäki
Feb 26, 2021·Pflügers Archiv : European journal of physiology·Kalina AndrysiakJózef Dulak
May 15, 2021·Cell & Bioscience·Tianyuan Shi, Martin Cheung
Jul 16, 2021·Frontiers in Cell and Developmental Biology·Eric K N GähwilerMaximilian Y Emmert

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
flow cytometry
fluorescence-activated cell sorting
PCR
dissection
transfection
biopsies

Software Mentioned

Applied
CellOptiq
GraphPad
FACSDiva
Prism

Related Concepts

Related Feeds

Cell Fate Conversion By mRNA

mRNA-based technology is being studied as a potential technology that could be used to reprogram cell fate. This technique provides the potential to generate safe reprogrammed cells that can be used for clinical applications. Here is the latest research on cell fate conversion by mRNA.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.